S. Hess et al., A CYTOTOXIC CD40 P55 TUMOR-NECROSIS-FACTOR RECEPTOR HYBRID DETECTS CD40 LIGAND ON HERPESVIRUS SAIMIRI-TRANSFORMED T-CELLS/, European Journal of Immunology, 25(1), 1995, pp. 80-86
The B cell activation molecule CD40 and the p55 tumor necrosis factor
receptor (p55TNFR) belong to the same family of structurally conserved
proteins. We constructed a chimeric receptor consisting of the CD40 e
xtracellular and transmembrane domains and the p55TNFR intracellular d
omain. This receptor hybrid retained the biological activity and the l
igand specificity of the respective wild-type receptor domains. Thus i
t exerted a marked cytotoxic effect in three different transfected cel
l. lines after activation not only with anti-CD40 antibody but also wi
th CD40 ligand (CD40L) in soluble and membrane-bound forms. Using hybr
id-transfected baby hamster kidney cells we demonstrated that herpesvi
rus saimiri-transformed human CD4(+) T lymphocytes constitutively expr
ess bioactive CD40 ligand on their surface. The hybrid receptor-based
assay was highly specific for CD40 activating reagents and more sensit
ive than an assay measuring CD40-mediated B cell rescue from apoptosis
. Hence CD40/p55TNFR transfectants may be useful for dissecting CD40L-
mediated events in T-B cell interactions, and also to detect a defecti
ve CD40L molecule in putative hyper-IgM syndrome patients.